Orgenesis (NYSE:ORGS) Trading 7.6% Higher

Orgenesis Inc. (NYSE:ORGS)’s share price shot up 7.6% during mid-day trading on Monday . The company traded as high as $5.55 and last traded at $5.40, 113,213 shares were traded during mid-day trading. An increase of 95% from the average session volume of 58,100 shares. The stock had previously closed at $5.02.

The company has a fifty day moving average of $3.83 and a two-hundred day moving average of $3.99.

Orgenesis (NYSE:ORGS) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.44 earnings per share (EPS) for the quarter. The firm had revenue of $9.12 million for the quarter.

Orgenesis Company Profile (NYSE:ORGS)

Orgenesis Inc, a service and research company, focus on the development and manufacture of cell therapy for advanced medicinal products in the field of regenerative medicine industry. It operates through two segments, Contract Development and Manufacturing Organizations (CDMO) and Cellular Therapy (CT) Business.

Read More: What does an equal weight rating mean?

Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.